SCHEMBL29373732

SCHEMBL29373732

C=C(C)C(OC(=O)c1cc(Oc2ccc(C(F)(F)F)cc2Cl)ccc1[N+](=O)[O-])C(=O)OCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.61
▸ KMT2A Q03164 3/20 0.61
▸ TDP1 Q9NUW8 2/20 0.61
▸ TTR P02766 1/20 0.61
▸ PPOX P50336 1/20 0.61
▸ FFAR1 O14842 3/20 0.42
▸ MRGPRX4 Q96LA9 1/20 0.42
▸ LMNA P02545 5/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ PPARD Q03181 2/20 0.38
▸ HPD P32754 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ CCR6 P51684 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ GPR55 Q9Y2T6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL143920 1.00 MEN1 (0.61) MEN1KMT2ATDP1TTRPPOX
SCHEMBL30185879 1.00 MEN1 (0.61) MEN1KMT2ATDP1TTRPPOX
SCHEMBL10830722 0.94 MEN1 (0.67) MEN1KMT2ATDP1TTRPPOX
SCHEMBL10992818 0.93 MEN1 (0.64) MEN1KMT2ATDP1TTRPPOX
SCHEMBL10536733 0.91 MEN1 (0.62) MEN1KMT2ATDP1TTRPPOX
SCHEMBL21381206 0.89 MEN1 (0.61) MEN1KMT2ATDP1TTRPPOX
Lactofen SCHEMBL30606811 0.88 MEN1 (0.66) MEN1KMT2ATDP1TTRPPOX
Lactofen SCHEMBL8536001 0.88 MEN1 (0.66) MEN1KMT2ATDP1TTRPPOX
Lactofen SCHEMBL30359837 0.88 MEN1 (0.66) MEN1KMT2ATDP1TTRPPOX
Lactofen SCHEMBL29462400 0.88 MEN1 (0.66) MEN1KMT2ATDP1TTRPPOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665151-A1 HERBICIDAL MIXTURES Bayer Aktiengesellschaft (DE) 2025-12-24 — — EP disclosed
EP-4651716-A1 SOPHOROLIPIDS AND SOPHOROLIPID DERIVATIVES AS TANK MIX ADDITIVES AND ADJUVANTS IN CROP PROTECTION FORMULATIONS Locus Solutions IPCO, LLC (US) 2025-11-26 — — EP disclosed
US-20250223268-A1 4-Methylsulfonylbenzamide Compound, Preparation Method, Herbicidal Composition And Use JIANGSU FLAG CHEMICAL INDUSTRY CO., LTD. (CN) 2025-07-10 — — US disclosed
WO-2025122384-A1 METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE MONSANTO TECHNOLOGY LLC (US) 2025-06-12 — — WO disclosed
WO-2025078128-A1 PYRIDAZIN-3-ONE-4-YLOXADIAZINES AS NOVEL FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 2025-04-17 — — WO disclosed
CN-115484824-B Compound combination having excellent herbicidal activity 拜耳公司 2025-04-04 — — CN disclosed
EP-4521922-A1 LOW DRIFT AQUEOUS LIQUID FORMULATIONS FOR LOW, MEDIUM, AND HIGH SPRAY VOLUME APPLICATION Bayer Aktiengesellschaft (DE) 2025-03-19 — — EP disclosed
CN-115003656-B [ (1, 4, 5-Trisubstituted 1H-pyrazol-3-yl) sulfanyl ] acetic acid derivatives and salts thereof and their use as active herbicidal ingredients 拜耳公司 2025-03-04 — — CN disclosed
CN-111356368-B Herbicidally active bicyclic benzamides 拜耳公司 2025-02-25 — — CN disclosed
WO-2025032038-A1 PYRIDAZIN-4-YLOXADIAZINES AS NOVEL FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 2025-02-13 — — WO disclosed
EP-3759105-B1 HERBICIDALLY ACTIVE SUBSTITUTED BICYCLIC BENZOYLAMIDES BAYER AG (DE) 2022-04-06 — — EP disclosed
WO-2022058327-A1 SUBSTITUTED UREAS AND DERIVATIVES AS NEW ANTIFUNGAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2022-03-24 — — WO disclosed
EP-3965573-A1 HIGH SPREADING AND UPTAKE ULV FORMULATIONS Bayer Aktiengesellschaft (DE) 2022-03-16 — — EP disclosed
EP-3965576-A1 ACTIVE COMPOUND COMBINATION Bayer Aktiengesellschaft (DE) 2022-03-16 — — EP disclosed
EP-3965575-A1 ACTIVE COMPOUND COMBINATIONS Bayer CropScience LP (US) 2022-03-16 — — EP disclosed
EP-3965574-A1 ULV FORMULATIONS WITH ENHANCED UPTAKE Bayer Aktiengesellschaft (DE) 2022-03-16 — — EP disclosed
EP-3965572-A1 ULV FORMULATIONS WITH ENHANCED UPTAKE Bayer Aktiengesellschaft (DE) 2022-03-16 — — EP disclosed
EP-3965570-A1 HIGH SPREADING ULV FORMULATIONS FOR HERBICIDES Bayer Aktiengesellschaft (DE) 2022-03-16 — — EP disclosed
CN-114025608-A ULV formulations with high spreading and absorption 拜耳公司 2022-02-08 — — CN disclosed
CN-114007421-A Absorption-promoting ULV formulations 拜耳公司 2022-02-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250223268-A1 4-Methylsulfonylbenzamide Compound, Preparation Method, Herbicidal Composition And Use MSRB3, SRM, STS MEN1 3431/4885KMT2A 19/4885TDP1 3215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback